MedPath

Clinical Research of Diquas ophthalmic solution 3% on corneal epithelial barrier function in dry eye

Not Applicable
Conditions
Dry eye
Registration Number
JPRN-UMIN000021884
Lead Sponsor
Collaborative joint clinical research organized with Kyorin university School of Medicine and Santen Pharmaceutical Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with a history of allergy to fluorescein Patients who have allergic conjunctivitis, and have possibilities to get worse during study phase. Experience in using Diquas ophthalmic solution 3%. The investigator or subinvestigator has judged that the patient is ineligible as study subject.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath